Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Obeidat Y, Cholankeril G. Non-cirrhotic hyperammonemia in adults: Recognition and management. World J Hepatol 2026; 18(11): 125669 [DOI: 10.4254/wjh.125669]
World J Hepatol. Nov 27, 2026; 18(11): 125669 Published online Nov 27, 2026. doi: 10.4254/wjh.125669
Non-cirrhotic hyperammonemia in adults: Recognition and management
Yasmeen Obeidat, George Cholankeril
Yasmeen Obeidat, Department of Gastroenterology and Hepatology, Marshall University Joan C. Edwards School of Medicine, Huntington, WV 25701, United States
George Cholankeril, Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, TX 77030, United States
Author contributions: Obeidat Y designed the review, performed the literature search, and drafted the manuscript; Cholankeril G critically revised the manuscript for important intellectual content and supervised the work; both authors approved the final version.
AI contribution statement: Artificial intelligence tools, specifically Claude (Anthropic), were used for language editing, formatting assistance, and preparation of the schematic diagrams in Figures 1-4. No AI tool was used to generate research data, interpret results, formulate conclusions, or select references. All AI-assisted content, including the figures, was critically reviewed and verified by the authors, who take full responsibility for the accuracy, originality, and integrity of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Corresponding author: Yasmeen Obeidat, MD, Associate Professor, Department of Gastroenterology and Hepatology, Marshall University Joan C. Edwards School of Medicine, 1249 15th Street, Huntington, WV 25701, United States. obeidaty@marshall.edu
Received: July 14, 2026 Revised: August 25, 2026 Accepted: September 20, 2026 Published online: November 27, 2026 Processing time: 129 Days and 21.1 Hours
Abstract
In adults, an elevated ammonia level is almost reflexively attributed to cirrhosis. Yet hyperammonemia also occurs in patients with structurally normal livers, in whom the underlying cause is often missed. This delay matters because hyperammonemic brain injury depends on both the magnitude and duration of ammonia elevation. This review organizes the non-cirrhotic causes by mechanism. Ammonia production increases with urease-producing urinary tract infections, Ureaplasma or Mycoplasma infection after lung transplantation, heavy nitrogen loads, malignancy and chemotherapy, and urinary diversion. Clearance is impaired in adult-onset urea cycle disorders, with drugs such as valproate, post-gastric bypass, and when portal blood bypasses the liver through a portosystemic shunt. We outline a practical diagnostic approach: Confirm a true elevation using a properly handled sample, exclude cirrhosis, then use targeted testing, including plasma amino acids, urine orotic acid, acid-base assessment, acylcarnitine and zinc levels, and Doppler or cross-sectional imaging, to distinguish among these mechanisms. Management proceeds on two tracks: Lowering ammonia while simultaneously treating the underlying cause, which can be curative in several conditions. Early measurement of ammonia in patients with unexplained encephalopathy and normal liver tests can prevent avoidable neurologic injury.
Core Tip: In adults, a high ammonia level is usually attributed to cirrhosis, yet a substantial minority of patients have normal livers. Sorting these cases by mechanism-excess ammonia production or impaired clearance-turns a broad differential into a focused, stepwise workup. Many causes are reversible, including urease-producing infections, drugs such as valproate, portosystemic shunts, and unmasked urea cycle disorders. Measuring ammonia early in patients with unexplained encephalopathy and normal liver tests, while initiating ammonia-lowering therapy and investigating the underlying cause, can prevent avoidable brain injury.